Next Article in Journal
An Altered Circadian Clock Coupled with a Higher Photosynthesis Efficiency Could Explain the Better Agronomic Performance of a New Coffee Clone When Compared with a Standard Variety
Next Article in Special Issue
Adiponectin as Link Factor between Adipose Tissue and Cancer
Previous Article in Journal
Comparative Dissection of Three Giant Genomes: Allium cepa, Allium sativum, and Allium ursinum
Previous Article in Special Issue
Global Transcriptional Insights of Pollen-Pistil Interactions Commencing Self-Incompatibility and Fertilization in Tea [Camellia sinensis (L.) O. Kuntze]
Article Menu
Issue 3 (February-1) cover image

Export Article

Open AccessReview

Long Non-Coding RNA and Acute Leukemia

Programa de Doctorado, Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico
Unidad de Investigación Médica en Epidemiología Clínica, UMAE Hospital de Pediatría “Dr. Silvestre Frenk Freund”, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico
Unidad de Investigación en Enfermedades Metabólicas y Endócrinas, Hospital Juárez de México, Mexico City 07760, Mexico
Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 735;
Received: 6 October 2018 / Revised: 20 October 2018 / Accepted: 22 October 2018 / Published: 9 February 2019
PDF [616 KB, uploaded 19 February 2019]


Acute leukemia (AL) is the main type of cancer in children worldwide. Mortality by this disease is high in developing countries and its etiology remains unanswered. Evidences showing the role of the long non-coding RNAs (lncRNAs) in the pathophysiology of hematological malignancies have increased drastically in the last decade. In addition to the contribution of these lncRNAs in leukemogenesis, recent studies have suggested that lncRNAs could be used as biomarkers in the diagnosis, prognosis, and therapeutic response in leukemia patients. The focus of this review is to describe the functional classification, biogenesis, and the role of lncRNAs in leukemogenesis, to summarize the evidence about the lncRNAs which are playing a role in AL, and how these genes could be useful as potential therapeutic targets. View Full-Text
Keywords: long non-coding RNAs; cancer; acute leukemia; therapeutic targets long non-coding RNAs; cancer; acute leukemia; therapeutic targets

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Cruz-Miranda, G.M.; Hidalgo-Miranda, A.; Bárcenas-López, D.A.; Núñez-Enríquez, J.C.; Ramírez-Bello, J.; Mejía-Aranguré, J.M.; Jiménez-Morales, S. Long Non-Coding RNA and Acute Leukemia. Int. J. Mol. Sci. 2019, 20, 735.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top